- Home
- FCFS vs ARWR Comparison
FCFS vs ARWR Comparison
Compare FCFS & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FCFS | ARWR |
|---|---|---|
| Founded | 1988 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 5.6B |
| IPO Year | 1991 | 1993 |
Fundamental Metrics
Financial Performance| Metric | FCFS | ARWR |
|---|---|---|
| Price | $158.50 | $70.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $168.75 | $57.90 |
| AVG Volume (30 Days) | 237.4K | ★ 3.1M |
| Earning Date | 01-29-2026 | 11-25-2025 |
| Dividend Yield | ★ 1.08% | N/A |
| EPS Growth | ★ 27.90 | N/A |
| EPS | ★ 6.92 | N/A |
| Revenue | ★ $3,486,435,000.00 | $829,448,000.00 |
| Revenue This Year | $8.28 | N/A |
| Revenue Next Year | $10.44 | N/A |
| P/E Ratio | $22.56 | ★ N/A |
| Revenue Growth | 3.86 | ★ 23258.15 |
| 52 Week Low | $100.24 | $9.57 |
| 52 Week High | $166.08 | $71.50 |
Technical Indicators
Market Signals| Indicator | FCFS | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 52.28 | 77.96 |
| Support Level | $154.57 | $60.29 |
| Resistance Level | $163.25 | $71.50 |
| Average True Range (ATR) | 4.68 | 5.05 |
| MACD | -0.10 | 1.95 |
| Stochastic Oscillator | 70.51 | 95.85 |
Price Performance
Historical ComparisonAbout FCFS FirstCash Holdings Inc.
FirstCash Holdings Inc operates pawn stores in the United States and Latin America. Its primary business involves making small loans secured by personal property. The the company has three reportable segments: U.S. pawn; Latin America pawn; and Retail POS payment solutions (AFF). It derives majority revenue from U.S. Pawn segment. These pawn loans give the borrower the option of either repaying the loans with interest or forfeiting the property without further penalty. Geographically operates in USA, Mexico, Latin America, with maximum revenue from USA.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.